NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
118.01
Dollar change
-1.16
Percentage change
-0.97
%
IndexS&P 500 P/E29.11 EPS (ttm)4.05 Insider Own0.38% Shs Outstand283.94M Perf Week1.62%
Market Cap33.52B Forward P/E19.49 EPS next Y6.06 Insider Trans-1.16% Shs Float282.96M Perf Month4.18%
Enterprise Value35.53B PEG3.63 EPS next Q1.37 Inst Own90.70% Short Float1.45% Perf Quarter1.13%
Income1.17B P/S5.06 EPS this Y5.42% Inst Trans1.04% Short Ratio1.83 Perf Half Y-13.29%
Sales6.63B P/B5.46 EPS next Y8.60% ROA10.13% Short Interest4.11M Perf YTD-12.16%
Book/sh21.61 P/C22.56 EPS next 5Y8.01% ROE18.88% 52W High153.84 -23.29% Perf Year-11.33%
Cash/sh5.23 P/FCF28.19 EPS past 3/5Y3.97% 5.63% ROIC12.29% 52W Low96.43 22.38% Perf 3Y-0.50%
Dividend Est.0.98 (0.83%) EV/EBITDA19.06 Sales past 3/5Y1.00% 4.75% Gross Margin53.95% Volatility1.87% 2.07% Perf 5Y32.18%
Dividend TTM0.97 (0.82%) EV/Sales5.36 EPS Y/Y TTM-4.08% Oper. Margin23.94% ATR (14)2.71 Perf 10Y196.43%
Dividend Ex-DateJul 01, 2025 Quick Ratio1.60 Sales Y/Y TTM0.56% Profit Margin17.59% RSI (14)56.23 Recom2.10
Dividend Gr. 3/5Y6.42% 7.33% Current Ratio2.09 EPS Q/Q-28.23% SMA201.01% Beta1.24 Target Price137.50
Payout21.31% Debt/Eq0.57 Sales Q/Q6.04% SMA505.29% Rel Volume0.71 Prev Close119.17
Employees17900 LT Debt/Eq0.55 EarningsMay 28 AMC SMA200-8.16% Avg Volume2.25M Price118.01
IPONov 18, 1999 Option/ShortYes / Yes EPS/Sales Surpr.3.57% 2.54% Trades Volume1,595,430 Change-0.97%
Date Action Analyst Rating Change Price Target Change
Feb-10-25Upgrade Barclays Underweight → Equal Weight $135 → $145
Aug-28-24Initiated Wells Fargo Overweight $157
Jul-10-24Upgrade Citigroup Neutral → Buy $135 → $150
Jun-27-24Downgrade Wolfe Research Outperform → Peer Perform
Jun-03-24Resumed Jefferies Hold $135
Apr-05-24Upgrade Stifel Hold → Buy $145 → $163
Dec-13-23Initiated Wolfe Research Outperform $140
Dec-12-23Downgrade BofA Securities Buy → Neutral $130 → $133
Nov-17-23Downgrade UBS Buy → Neutral $163 → $125
Sep-28-23Initiated Bernstein Mkt Perform $123
Today 12:43PM
Jun-27-25 11:30AM
Jun-24-25 01:40AM
Jun-19-25 08:30AM
Jun-18-25 06:00AM
11:31PM Loading…
Jun-16-25 11:31PM
Jun-12-25 08:00AM
Jun-02-25 09:15AM
May-30-25 09:11AM
May-29-25 04:23PM
02:49PM
10:13AM
09:21AM
09:15AM
03:04AM
11:22PM Loading…
May-28-25 11:22PM
05:32PM
05:30PM
05:20PM
04:58PM
04:21PM
04:15PM
04:05PM
08:30AM
May-27-25 08:01AM
08:00AM
03:02AM
May-25-25 05:00AM
May-22-25 09:01PM
09:15AM
04:05PM Loading…
May-21-25 04:05PM
08:30AM
May-20-25 08:00AM
May-15-25 04:14PM
May-14-25 08:50AM
May-12-25 07:25PM
May-08-25 12:35AM
May-05-25 07:40AM
12:41AM
May-02-25 12:10PM
May-01-25 08:00AM
Apr-30-25 09:50PM
09:01AM
Apr-29-25 09:05AM
08:50AM
Apr-28-25 01:19PM
11:37AM
08:50AM
Apr-24-25 09:52AM
08:30AM
08:00AM
Apr-21-25 06:15PM
Apr-19-25 01:25AM
Apr-18-25 05:03AM
Apr-17-25 08:00AM
Apr-16-25 04:05PM
Apr-15-25 09:50PM
Apr-11-25 08:50AM
Apr-10-25 01:28PM
Apr-08-25 07:16PM
Apr-07-25 12:50PM
Apr-03-25 07:00AM
Mar-30-25 04:14PM
Mar-29-25 01:55AM
Mar-28-25 04:39PM
12:01PM
11:30AM
09:00AM
Mar-26-25 09:20AM
Mar-25-25 11:30AM
09:51AM
Mar-24-25 09:39AM
08:00AM
Mar-20-25 01:37PM
Mar-19-25 08:00AM
Mar-12-25 05:03AM
05:01AM
Mar-10-25 08:19AM
Mar-03-25 09:15AM
Feb-27-25 09:29PM
07:20PM
07:56AM
02:20AM
Feb-26-25 09:46PM
06:00PM
05:15PM
04:34PM
04:12PM
04:04PM
Feb-25-25 08:05AM
Feb-23-25 08:50AM
Feb-21-25 09:15AM
Feb-19-25 04:05PM
Jan-31-25 04:36PM
Jan-24-25 05:59PM
08:00AM
Jan-16-25 08:00AM
Jan-14-25 08:00PM
Jan-13-25 08:00AM
Jan-02-25 08:47AM
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics, as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brown Judy LDirectorJun 18 '25Sale116.5389041,677Jun 23 12:12 PM
Podolsky Daniel KDirectorMar 31 '25Sale116.461,819211,84435,737Apr 02 05:07 PM
Podolsky Daniel KDirectorMar 31 '25Proposed Sale116.461,819211,845Mar 31 01:21 PM
Gonsalves RodneyV.P., Corporate ControllerMar 17 '25Sale121.981,908232,69121,786Mar 18 02:17 PM
Gonsalves RodneyOfficerMar 17 '25Proposed Sale121.961,908232,692Mar 17 03:14 PM
Rataj Sue H.DirectorMar 06 '25Sale126.386,971881,00919,640Mar 07 04:11 PM
Rataj Sue H.DirectorMar 06 '25Proposed Sale126.386,971881,005Mar 06 02:27 PM
MCDONNELL PADRAIGPresident and CEOJan 21 '25Sale150.001,911286,65039,652Jan 23 07:20 PM
MCDONNELL PADRAIGOfficerJan 21 '25Proposed Sale150.001,911286,650Jan 21 10:53 AM
MCDONNELL PADRAIGPresident and CEOSep 27 '24Sale150.00477,05024,071Sep 30 01:08 PM
Grau DominiqueSenior Vice PresidentSep 26 '24Sale145.009,9901,448,55040,011Sep 27 05:02 PM
Grau DominiqueSenior Vice PresidentSep 26 '24Sale145.005,010726,45046,762Sep 27 05:02 PM
MCDONNELL PADRAIGOfficerSep 27 '24Proposed Sale150.00477,050Sep 27 12:19 PM
Grau DominiqueOfficerSep 26 '24Proposed Sale145.0015,0002,175,000Sep 26 02:52 PM
MCDONNELL PADRAIGPresident and CEOAug 22 '24Sale145.001,958283,91024,118Aug 23 11:43 AM
MCDONNELL PADRAIGOfficerAug 22 '24Proposed Sale145.001,958283,910Aug 22 12:39 PM
MCDONNELL PADRAIGPresident and CEOJul 26 '24Sale140.001,958274,12026,076Jul 30 10:42 AM
MCDONNELL PADRAIGOfficerJul 26 '24Proposed Sale140.001,958274,120Jul 26 10:56 AM